All Updates

All Updates

icon
Filter
Earnings/results
Rubicon reports Q4 2022 update; indicates a significant reduction in net losses
Waste Recovery & Management Tech
Mar 8, 2023
This week:
Funding
EKORE raises EUR 1.3 million (~ USD 1 million) in seed funding to strengthen platform
Digital Twin
Dec 20, 2024
Funding
Culina Health raises USD 7.9 million in Series A funding to expand offerings and expand team
Functional Nutrition
Dec 19, 2024
FDA approval
ViGeneron receives IND clearance for VG801 gene therapy
Cell & Gene Therapy
Dec 19, 2024
Product updates
Reflex Aerospace ships first commercial satellite SIGI
Next-gen Satellites
Dec 19, 2024
Partnerships
Vast partners with SpaceX for two private astronaut missions to ISS
Space Travel and Exploration Tech
Dec 19, 2024
Management news
Carbios appoints Philippe Pouletty as interim CEO amid plant delay
Waste Recovery & Management Tech
Dec 19, 2024
Funding
BlueQubit raises USD 10 million in seed funding to develop quantum platform
Quantum Computing
Dec 19, 2024
FDA approval
Arbor Biotechnologies receives FDA clearance for ABO-101 IND application
Human Gene Editing
Dec 19, 2024
Funding
Partnerships
Personalis partners with Merck and Moderna for cancer therapy development and investment
Precision Medicine
Dec 19, 2024
Partnerships
COTA partners with Guardant Health to develop clinicogenomic data solutions for cancer research
Precision Medicine
Dec 19, 2024
Waste Recovery & Management Tech

Waste Recovery & Management Tech

Mar 8, 2023

Rubicon reports Q4 2022 update; indicates a significant reduction in net losses

Earnings/results

  • Rubicon reported a revenue of USD 166 million in Q4 2022, lagging analyst estimates of USD 199 million. However, the revenue increased 2% YoY, while the adjusted gross profit reached USD 13.4 million, remaining roughly flat from Q4 2021 (-1% YoY). The revenue for FY 2022 increased by 16% YoY to USD 675 million.

  • The company attributed the revenue growth to increased service with both new and existing customers across business lines. The negligible decline in adjusted gross profit was primarily driven by one-time customer expenses but was largely offset by stronger performance in the SaaS product lines.

  • The company's adjusted EBITDA loss was USD 17.6 million in Q4 2022, a slight improvement from a loss of USD 19.5 million in Q4 2021. Net losses reduced significantly in Q4 2022 to USD 18 million, compared to USD 30.3 million in Q4 2021, due to increased revenue and a decrease in general and administrative expenses (-50% YoY). This reduction in losses was partially driven by a USD 10.4 million gain on the settlement of certain management bonuses. The reduction in losses was also attributed to the company's merger with Founder SPAC and strategic shift.

  • The company expects to generate a positive adjusted EBITDA for Q4 2023.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.